See also this year's filing and all EDGAR filings for this company.
PDF Report 0000896262_2011_Amedisys_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000896262')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0000896262, Amedisys INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 844,805,000 |
| 1 | AssetsNonCurrent | 22,536,000 |
| 2 | AssetsCurrent | 293,930,000 |
| 3 | PropertyPlantAndEquipment | 138,554,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 151,520,000 |
| 6 | LiabilitiesCurrent | 216,304,000 |
| 7 | remainder_Liabilities | 52,286,000 |
| 8 | LaborExpense | 357,502,000 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 34,589,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 1,121,027,000 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 1,626,391,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,299,825,000 |
| 1 | Liabilities | 420,110,000 |
| 2 | Expenses | 1,513,118,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 879,715,000 |
| 5 | NetIncome | 113,273,000 |
| 6 | ComprehensiveNetIncome | 113,273,000 |
| 7 | BaseVar | 2,429,722,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.62 |
| 9 | EconomicCapitalRatio | 2.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
